Article

Arkeabio has appointed Dr. Zach Serber as Chief Technology Officer, aiming to advance its innovative solution for reducing methane emissions from cattle. With over 20 years in synthetic biology, Dr.

Serber's expertise will guide the company's scientific strategy as it prepares for product validation and commercial deployment, targeting a significant impact on climate change and agricultural productivity. The company plans to transition animal studies to full field trials in 2026, with a commercial launch shortly thereafter, aligning with global emissions targets.